Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arlene Chapman, MD
University of Chicago, Chicago, IL USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Los Angeles
Los Angeles, California, United States
- University of Chicago Medicine & Biological Sciences
Chicago, Illinois, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Brookview Hills Research Associates, Llc
Winston-Salem, North Carolina, United States
- Northeast Clinical Research Center, Llc
Bethlehem, Pennsylvania, United States
- Nephrology Associates of Northern Virginia, Inc.
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Sept 2020
- Primary completion
- 29 Jul 2022
- Completion
- 29 Jul 2022
- Last update posted
- 10 Apr 2023
- Registered enrollment
- 7
- Registry id
- NCT04152837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.